Am J Med Genet A by Zhu, Jin Liang et al.
Hospitalizations among persons with Down syndrome: a 
national cohort study in Denmark
Jin Liang Zhu1, Henrik Hasle2, Adolfo Correa3, Diana Schendel3, J. M. Friedman4, Jørn 
Olsen1, and Sonja A. Rasmussen3
1Section of Epidemiology, Department of Public Health, University of Aarhus, Denmark
2Department of Pediatrics, Aarhus University Hospital, Skejby, Aarhus, Denmark
3Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
4Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
Summary
Background—Most persons with Down syndrome (DS) now survive to adulthood, but their 
health care needs beyond childhood are not well described. We examined hospitalizations among 
persons with DS in Denmark.
Methods—We followed 3,212 persons with DS (1910-2007), identified from the Danish 
Cytogenetic Register, and a random sample of persons without DS from the general population (as 
comparison group), through the National Hospital Register from January 1, 1977, to May 31, 
2008. Poisson regression was used to calculate rate ratios for numbers of overnight hospital 
admissions and hospital days.
Findings—During this time period, persons with DS had more than twice the rate of hospital 
admissions and nearly three times as many bed-days as the population as whole. Malformations, 
diseases of the respiratory system, and diseases of the nervous system or sensory organs were the 
principal indications for hospital admissions. The higher rate ratios for hospital admissions were 
mainly seen among persons less than 20 years of age, and hospitalization for neoplasms or for 
diseases of the musculoskeletal system or connective tissue was much less frequent than expected 
among adults with DS. Persons with DS who had congenital heart defects were far more likely to 
be hospitalized than those without.
Interpretation—Persons with DS in Denmark are hospitalized more frequently and for more 
days than persons without DS; however, hospitalization usage differs by age (with a higher burden 
at younger ages) and by presence of a congenital heart defect. As survival among persons with DS 
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continues to improve, these data are helpful for health care planning, although results may be 
different within other health care systems.
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Introduction
Down syndrome (DS), caused by an extra copy of the genetic material on chromosome 21, 
is the most common identifiable genetic cause of cognitive impairment, occurring in 
approximately one in 700 births.1 People with DS have congenital heart defects,2 and 
gastrointestinal tract defects more often than the general population.3,4 In addition, some 
studies show that persons with DS are at increased risk for other health problems,5 including 
childhood leukemia,6 hypothyroidism,7 infectious diseases,8,9 certain autoimmune disorders 
like celiac disease and diabetes,7,10 and Alzheimer's disease.11
Most people with DS in countries with good health care now survive to adulthood,12,13 and 
planning for their health care requires information on the health problems they experience as 
they age.14-16 Most information about health conditions and health care utilization for 
persons with DS is still limited to childhood,17-19 and most studies are based on small 
sample sizes. In addition, studies on DS co-morbidities are often done using selected clinical 
samples,20 that may not be representative of all people with DS.
We conducted a population-based follow-up study using nationwide Danish health registry 
data collected prospectively as part of routine health care to examine patterns of 
hospitalizations among children and adults with DS in comparison to the general population.
Methods
Study design
This is a national register-based follow-up study of people with DS in Denmark. First, a 
cohort of all persons with DS was identified using the Danish Cytogenetic Register. Then a 
reference cohort was randomly selected from the general population in the Civil Registration 
System, matching on birth year. The DS and reference cohorts were linked to a number of 
national registers, including the Civil Registration System and the National Patient Register. 
All data linkages were based upon the unique personal identification number assigned to 
each Danish resident since 1968. The personal identification number includes information 
on birth date and sex and allows complete follow-up for death, emigration, and 
hospitalizations.
Identification of persons with DS
The Danish Cytogenetic Register was founded in 1968 to collect information on 
constitutional chromosomal abnormalities in Denmark. The register is based on reports from 
cytogenetic laboratories throughout the country and provides virtually complete coverage of 
constitutional chromosomal abnormalities diagnosed in Denmark since 1961. The 
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Cytogenetic Register contained information on 3551 individuals with a postnatal cytogenetic 
diagnosis of DS by 2007 (i.e. including those who were born before April 1968 and alive on 
April 1, 1968 and those who were born between April 1968 and December 2007). A 
karyotype based on a peripheral blood sample was available from all patients. All reported 
karyotypes were reviewed (by SAR, JMF and HH), with five patients reclassified as not 
having trisomy 21 and 16 individuals excluded because they had another cytogenetic 
aberration (such as XYY, XXY, XXX, translocations, inversions, or deletion). We also 
excluded 114 patients with mosaic trisomy 21, 198 patients who died or emigrated before 
January 1, 1977, and six patients who died on the date of birth. A total of 3212 patients with 
non-mosaic DS (born between 1910 and 2007), including 3075 with standard trisomy 21 and 
137 with Robertsonian translocations, remained for analysis (Table 1).
Selection of reference cohort
Based on the initial cohort of persons with DS (n=3551), 71020 persons without DS were 
randomly selected from the Civil Registration System, with a sampling frame of 20:1 and 
matching on birth year. With the subsequent exclusion of 135 cases with DS from the initial 
cohort (see above), 2700 matched persons in the reference cohort were dropped. We also 
excluded from the reference cohort 1074 persons who died or emigrated before January 1, 
1977, and 42 persons who died on the date of birth, resulting in 67,204 individuals available 
for comparison in the final reference cohort (Table 1).
Data on hospitalizations
Data on hospitalizations were obtained by data linkage to the National Patient Register using 
the unique personal identification numbers. The National Hospital Register has collected 
nationwide data on all hospital admissions since 1977. Up to 20 diagnoses for each 
admission were recorded in the register, using the 8th Revision of International 
Classification of Diseases (ICD8) before 1994 and the 10th Revision of International 
Classification of Diseases (ICD10) since 1994. Diseases were categorized on organ systems 
(Table 2).
We included all data on inpatient hospitalizations lasting more than one day (i.e., the 
discharge date was different from the admission date) between January 1, 1977, and May 31, 
2008. We used all available information on diagnoses related to each hospitalization; one 
hospitalization counted once for “any” hospitalization and also counted in all relevant 
disease categories. Outpatient use is not included in this analysis.
Information on covariates and civil status
Information on sex (female, male) and date of birth (before April 1968, 1968-1979, 
1980-1989, 1990-1999, 2000-2007) was extracted from the personal identification number. 
Information on congenital heart defect (ICD8: 746-747·4; ICD10: Q20-Q26) was obtained 
from the National Hospital Register, and information on vital status and emigration was 
obtained from the Civil Registration System.
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We used Poisson regression to calculate rate ratios for the frequency of hospital admissions 
and number of hospital days among persons with DS compared with the reference cohort. 
Follow-up started at the date of birth for those born after January 1, 1977, or was left-
truncated at January 1, 1977, for those born before that date, and ended at date of death, date 
of emigration, or end of follow-up (May 31, 2008), whichever came first. DS is present at 
birth and, although not always diagnosed immediately, we started our observation at birth, 
assuming that all children with DS who died would be diagnosed prior to death. We used a 
robust method to calculate 95% confidence intervals, accounting for the dependence 
between hospitalizations within each person. We included sex and birth cohort as covariates 
in the Poisson regression models, and we also included age group as a covariate for analyses 
among all persons.
First, we performed Poisson regression analyses for hospital admission for any reason, 
comparing individuals with DS to the reference cohort at any age and within each age group 
(<1, 1-4, 5-19, 20-49, and 50+ years). Then we conducted Poisson regression analyses for 
hospital admission for each disease category, comparing individuals with DS to the 
reference cohort at any age and within each age group. Next, we performed similar analyses 
on hospital days. Finally, we estimated associations of sex, age group, birth cohort, and 
congenital heart defects with the overall frequency of hospital admission and number of 
hospital days among persons with DS. All analyses were performed with STATA software 
(version SE 9·2).
Role of the funding source
The US federal government, the funding source for this study, employs some of the study 
authors (AC, DS, and SAR). The report received approval for publication from other 
employees of the US government. The first author had full access to all data in the study and 
he and the other authors had final responsibility for the decision to submit for publication.
Results
We followed 3,212 persons with DS for more than 30 years (from January 1, 1977 to May 
31, 2008), and recorded a total of 16,815 hospital admissions and 108,042 hospital days over 
63,489 person-years at risk. Among 67,204 individuals in the population-based reference 
cohort matched for birth year and followed over the same time period, there were 186,416 
hospital admissions and 980,246 hospital days over 1,520,470 person-years at risk.
Overall, persons with DS were admitted to hospital more than twice as often as the reference 
population (Table 3). The most common reasons for hospitalization among people with DS 
were malformations, diseases of the respiratory system, and diseases of the nervous system 
or sensory organs. Hospitalization for most causes was more frequent than expected among 
people with DS, compared to the reference cohort. For example, the rate ratio for 
hospitalization due to malformations (excluding chromosomal abnormalities) among people 
with DS was 22·7 (95% CI 21·7-23·7). The rate ratios of hospital admissions for diseases of 
the respiratory system and for diseases of the nervous system or sensory organs were five 
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times higher among persons with DS than those seen in the reference cohort. The highest 
rate ratios of hospital admission for persons with DS were seen before 20 years of age for 
almost all disease categories (Table 3). The rate ratios of hospitalization for neoplasms or 
diseases of the musculoskeletal system or connective tissue were lower than expected 
among adults with DS.
The pattern seen with days of hospitalization was similar, but the overall rate ratio for 
people with DS was even higher (2·7, 95% CI 2·6-2·8) (Table 4). Many diseases contributed 
to this high use, but malformations play an especially important role, and diseases of the 
respiratory system and diseases of the nervous system or sensory organs are very frequently 
responsible. The higher than expected use of hospital days in people with DS was mainly in 
the first five years of life. Strikingly low rate ratios for days of hospitalization were seen for 
neoplasms (0·1, 95% CI 0·1-0·2) or for diseases of the musculoskeletal system or connective 
tissue (0·2, 95% CI 0·1-0·3) among persons with DS over 50 years of age.
Analyses among DS persons showed that males had slightly more hospital admissions and 
used more bed-days than females. Children with DS under five years of age had the highest 
rate ratios for hospital admissions and for bed-days, whereas adults with DS aged 20-49 
years had the lowest rate ratios for admissions and for bed-days. The age-adjusted rate of 
hospital admission remained constant for those born in 1970s and later, but use of bed-days 
decreased with time. Persons with DS who had congenital heart defects had more hospital 
admissions and used more bed-days than persons with DS but no cardiac malformations 
(Table 5).
Discussion
In this historical population-based study that covers over 30 years of observation in 
Denmark, we found that people with DS had more overnight hospital admissions and spent 
more days in hospital than the general population, especially before the age of 20. 
Malformations, diseases of the respiratory system, and diseases of the nervous system or 
sensory organs were the main reasons for hospitalization, and persons with DS who also had 
congenital heart defects were often hospitalized than persons with DS but no cardiac 
malformations. The rate ratios of hospitalization for neoplasms or for diseases of the 
musculoskeletal system or connective tissue were much lower than expected among adults 
with DS. Use of hospital bed-days decreased over time among people with DS, following a 
general population trend.21
Our results were obtained in the Danish health care system with tax-paid hospital care to all 
residents free of charge, but our findings are generally consistent with reports from other 
countries or regions. A study of 117 children with DS aged 6-14 years in the United 
Kingdom reported that 88% of the children had been hospitalized at some time in their life, 
compared with 45% of children aged 11 years in the general population.22 Among 196 
neonates with DS who participated in a two-year randomized clinical trial in Holland, the 
hospital admission rate was about 2·8 times higher than expected in the neonatal period and 
about 2·2 times higher than expected thereafter.19 A study in the United States that used 
Tennessee Hospital Discharge Data System records from 1997 through 2002 showed that 
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children with DS had been hospitalized in the first year of life at a rate 4·1 times that 
expected nationally.18 A recent study examining health insurance hospital discharge claims 
in Taiwan in 2005 reported that the annual length of stay in hospital was twice as great for 
persons with DS as for the general population.23 Date from 120 Israeli adults with DS who 
were hospitalized at Hadassah Medical Centers during the years 1988-2007 revealed a 
similar trend.24
Our findings differ, however, from two previous studies from Denmark,25,26 which 
suggested that the number of hospital admissions was higher for 41-50-year-old adults with 
DS,25 but not for adolescents with DS,26 in comparison to the general population. However, 
both of these earlier studies included very small numbers of persons with DS identified in a 
Danish county (38 adults and 43 adolescents with DS).
Our findings indicating lower rates of hospitalization in recent years are consistent with 
recent studies from Sweden and Australia. The Swedish study identified 211 children with 
DS from registers and followed them up to 24 years of age. The authors found that the 
children with DS born between 1995 and 1998 had a shorter mean duration of neonatal and 
postneonatal care in hospital than those born between 1973 and 1980.17 The Australian 
study used data from two cross-sectional surveys in school-aged children with DS (5-17 
years old) and found fewer bed-days per hospital admission in 2004 than in 1997.27
We found that malformations, diseases of the respiratory system, and diseases of the nervous 
system or sensory organs were the main reasons for hospitalization among people with DS. 
This is in accordance with most studies.17-20,22,27-29 Our finding that persons with DS who 
have congenital heart defects were more likely to be hospitalized and to stay longer in the 
hospital than persons with DS but no cardiac malformations is also in agreement with 
previous reports.17,18,20
We found lower than expected rates of hospital admission and of days of hospitalization for 
neoplasms and diseases of the musculoskeletal system or connective tissue among adults 
with DS, especially those over 50 years of age. Common musculoskeletal diseases of later 
life such as osteoarthritis and osteoporosis are frequent among older adults with Down 
syndrome,30-32 so the low rate ratio for hospitalization related to musculoskeletal conditions 
in this age group is surprising. On the other hand, we were not surprised to find that 
hospitalization for neoplasia was infrequent among older adults with Down syndrome. The 
incidence of solid tumours33,34 and deaths from malignant neoplasms other than leukemia13 
have been reported to be much less frequent than expected among older adults with DS, and 
a recent health survey of older persons with DS also noted a low rate of cancer.31
Our study had a number of strengths. We identified an unselected national cohort of persons 
with DS and followed them over an extended period. The Danish Cytogenetic Register 
includes all persons diagnosed with DS during the study period in Denmark, and all patients 
had cytogenetic confirmation. We excluded persons with mosaic DS, because they had 
better survival compared to persons with non-mosaic DS35 and the number of persons with 
mosaic DS was too small for separate analysis. Our study included a random sample from 
the general population as a reference group. Information on hospitalizations for persons with 
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DS and the comparison population was obtained from the Danish National Hospital Register 
by using unique personal identification numbers.
Our study also has some limitations. Some errors in coding are likely to occur in the Danish 
National Hospital Register; however, we expect that the rate of errors would be similar 
among persons with and without DS. If hospitalization leads to a cytogenetic diagnosis of 
DS for persons born before 1968, some overestimation of health problems among these 
older persons with DS may have occurred. However, in more recent decades, most persons 
with DS in our cohort were diagnosed within the first year of life.
Our data show that persons with DS had more hospital admissions and more days 
hospitalized than the general population in Denmark, and that this was most pronounced 
during their childhood and adolescence. These population-based findings have important 
implications for planning health care as survival among persons with DS improves.
Panel: Research in Context
Systematic review
We searched PubMed in January 2012 for reports that contained the terms “Down 
syndrome” and “hospitalization” as well as relevant articles cited by these reports. Almost 
all previous studies on hospitalization are limited to children with DS, and most are based on 
small sample sizes.
Interpretation
In this national cohort study that followed 3,212 Danish persons with DS for more than 30 
years, we found that people with DS had more overnight hospital admissions and spent more 
days in hospital than the general population, in particular before the age of 20 years. 
Hospitalizations for most causes were more frequent among persons with DS than among 
persons without DS, while hospitalizations for neoplasms and for diseases of the 
musculoskeletal system or connective tissue occurred less commonly among adults with DS 
than among the general Danish population.
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Table 1
Distribution of persons with Down syndrome and reference population by sex and birth 
year, Denmark, 1977-2008
Persons with Down syndrome Reference population
n % n %
Total 3212 100·0 67204 100·0
Sex
 Female 1450 45·1 32865 48·9
 Male 1762 54·9 34339 51·1
Birth cohort
 Before April 1968 1158 36·1 23672 35·2
 1968-1979 621 19·3 14810 22·0
 1980-1989 475 14·8 9525 14·2
 1990-1999 614 19·1 12306 18·3
 2000-2007 344 10·7 6891 10·3
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Table 2
Disease categorization according to the International Classification of Diseases, the 8th 
and 10th revisions (ICD8 and ICD10 codes)
Disease categories ICD 10 codes ICD 8 codes
Any A00-Z99 000-796, E800-E999, N800-N999, Y00-
Y95
Infectious and parasitic diseases A00-B99 000-136
Neoplasms C00-D48 140-239
Diseases of the blood (-forming) organs, immunological 
disorders
D50-D89 280-289
Endocrine, nutritional and metabolic diseases E00-E90 240-279
Mental and behavioral disorders F00-F99 290-315
Diseases of the nervous system and the sensory organs G00-H95 320-389
Diseases of the circulatory system I00-I99 390-444·1, 444·3-458, 782·4
Diseases of the respiratory system J00-J99 460-519
Diseases of the digestive system K00-K93 520-577, 444·2
Diseases of the skin and subcutaneous tissue L00-L99 680-709
Diseases of the musculoskeletal system/connective tissue M00-M99 710-738
Diseases of the genitourinary system N00-N99 580-629, 792
Complications of pregnancy, childbirth and puerperium O00-O99 630-678
Certain conditions originating in the perinatal period P00-P96 760-779
Congenital malformations* Q00-Q89 740-759·2, 759·6-759
 Congenital heart defects Q20-D26 746-747·4
 Gastrointestinal tract defects Q38-Q45 750-751
 Other* Q00-Q18, Q27-Q37, Q50-Q89 740-745, 747·5-749, 752-759·2, 
759·6-759
Symptoms, signs, abnormal findings, ill-defined causes R00-R99 780-782·3, 782·5-791, 793-796
External causes of injury and poisoning V01-Y89, S00-T98 E800-E999, N800-N999
Factors influencing health status and contact with health services Z00-Z99, U00-U89 Y00-Y95
*
Chromosomal abnormalities (ICD10: Q90-Q99; ICD8: 759·3-759·5) were excluded in these categories.
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